相关实验视频
Updated: May 30, 2025

09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
15.9K
在Leishmaniasis中,TGF-β在免疫和病原性中起着双重作用
Susmita Barik1, Sanghamitra Goswami2, Prakash Kumar Nanda1
1Trident Academy of Creative Technology, Bhubaneswar, Odisha, India.
Cytokine
|January 28, 2025
概括
转化生长因子-β (TGF-β) 通过抑制免疫反应和促进组织纤维化来驱动Leishmania寄生虫的持久性. 调节TGF-β提供了一种治疗策略,以增强寄生虫清除和减少疾病病理.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
背景情况:
- 转化生长因子-β (TGF-β) 在莱什曼尼亚感染期间在调节免疫反应方面发挥着关键作用.
- TGF-β表现出双重功能,为莱什曼病的免疫抑制和病变产生作出贡献.
- 了解TGF-β的复杂作用对于开发有效的治疗策略至关重要.
研究的目的:
- 审查TGF-β在调节免疫偏差,纤维化和莱什曼病的发病过程中的复杂作用.
- 探索调节TGF-β信号通路的治疗潜力.
- 为选择性TGF-β通路干预提出新的策略.
主要方法:
- 在莱什曼病中对TGF-β进行实验研究的文献综述.
- 分析TGF-β对T细胞分化,巨细胞激活和纤维细胞活性的影响.
- 对TGF-β与IL-6等其他细胞因子结合作用的评估.
主要成果:
- TGF-β增强了调节性T细胞 (T-reg) 的分化,并抑制了巨细胞的激活,抑制了抗莱什曼病毒免疫力.
- TGF-β通过刺激纤维细胞增殖和细胞外基质的产生来促进纤维化,影响组织完整性.
- TGF-β与IL-6一起调节致病的Th17反应,加剧炎症和组织损伤.
结论:
- 针对性调节TGF-β信号提供了增强寄生虫清除和最小化免疫病理的潜力.
- 针对TGF-β的特定阶段干预策略可以恢复宿主免疫力,而不会造成炎症损伤.
- 选择性调节TGF-β通路代表了莱什曼病的有希望的治疗途径.
相关概念视频
T Cell Types and Functions
942
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
942
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

